Evaluate the incidence of hyperemia in patients using bimatoprost and to determine if simple interventions reduce its incidence and to assess the value of detailed instruction in increasing patient compliance and willingness to continue bimatoprost therapy, despite the occurrence of hyperemia...
Date First Received: June 30, 2006
Last Updated: May 30, 2007
Verified by: Innovative Medical, May 2007
Clinical Trial Phase: Phase 4 | Start Date:
Overall Status: Completed
Brief Summary
Official Title: “A Multicenter Evaluation of Methods to Reduce Hyperemia Associated With Bimatoprost Therapy for Glaucoma or Ocular Hypertension”
Condition Keyword(s):
Intervention(s):
Evaluate the incidence of hyperemia in patients using bimatoprost and to determine if simple interventions reduce its incidence and to assess the value of detailed instruction in increasing patient compliance and willingness to continue bimatoprost therapy, despite the occurrence of hyperemia.
Study Type: Interventional
Study Design: Non-Randomized, Open Label, Active Control, Single Group Assignment
Intervention(s) in this Clinical Trial
- Drug: Bimatoprost
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- · Male or female > 18 years of age
- No prior use of bimatoprost
- Diagnosis of open-angle glaucoma or ocular hypertension
- Ability to provide informed consent and likely to complete all study visits
Exclusion Criteria:
- · Known contraindication to bimatoprost
- Uncontrolled systemic disease
- Active ocular disease other than glaucoma or ocular hypertension
- Required use of ocular medications other than the study medications during the study (intermittent use of artificial tear solutions will be permitted)
- History of intraocular surgery within the last 3 months
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 18 Years
Maximum Age for this Clinical Trial: N/A
Clinical Trial Sponsor Information
Lead Sponsor: Innovative Medical
Overall Clinical Trial Officials and Contacts
Robert Noecker, MD Principal Investigator UPMC Eye Center
Additional Information
Information obtained from ClinicalTrials.gov on July 02, 2009
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00348062
Study ID Number: 5177
ClinicalTrials.gov Identifier: NCT00348062
Health Authority: United States: Institutional Review Board
Clinical Trials Authorship and Review
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
